Hone Health also acquires platform that provides at-home clinical services focused on longevity, wellness, and recovery.
Telemedicine clinic Hone Health has secured a $33 million Series A funding round to accelerate the company’s expansion into longevity-focused healthcare programs for men and women. The company also announced the acquisition of ivee, a platform that connects patients with clinicians providing a range of services focused on longevity, wellness and recovery, including IV therapy and phlebotomy.
The new funding is intended to support the evolution of Hone’s care model into a multi-faceted approach that combines medications, supplements, diet, exercise, stress management and sleep optimization. The company aims to provide immediate relief for existing symptoms while fostering long-term behavioral changes to counteract the progression of chronic diseases such as diabetes, cardiovascular disease, cancer, and dementia.
The acquisition of ivee will also allows Hone to extend its care delivery model beyond virtual consultations, enabling personalized treatment within patients’ homes.
Founded in 2020, Hone was initially focused on men’s health, with an emphasis on testosterone replacement therapy. Today, the company offers tailored programs for both men and women, with memberships starting at $129 per month. Services include live telehealth consultations, doctor-prescribed medications, and in-depth biomarker analysis of over 40 biomarkers, including indicators of thyroid function, sex hormone levels, lipid profile, a comprehensive metabolic panel and complete blood count.
Saad Alam, Hone’s co-founder and CEO, described the funding as a “pivotal moment” for the company.
“It allows us to capitalize on the shift from the broken primary care model to one that helps people live longer while staying healthy as they age,” he said. “With this new capital, we’ll push the boundaries of innovation, broaden our reach, and equip both men and women with the resources to achieve optimal health in midlife and beyond… The next decade will completely rewrite how we live our life from our 30s well into our 100s.”
The funding round, which brings the total raised by Hone to $39 million, saw participation from Tribe Capital, PIF, Republic Capital, Vibe VC, Humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs and Agent Capital, alongside a host of angel investors.
“Hone Health has quickly emerged as a leader in men’s health, prioritizing patient safety and delivering a unique, comprehensive solution that addresses critical market needs,” said Tribe Capital’s Ted Maidenberg. “We are excited to support their next phase of growth as they continue to expand their footprint into longevity and holistic healthcare.”
